| Mercury Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 538964 |
NSE Symbol : - |
P/E(TTM) : 20.77 |
|
ISIN Demat : INE947G01011 |
Div & Yield% : 0.46 |
EPS(TTM) : 36.59 |
|
Book Value(₹) : 483.97 |
Market Cap(₹Cr) : 91.20 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 15.96 | 20.44 | 18.35 | 19.01 | 18.14 | 20.66 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 15.96 | 20.44 | 18.35 | 19.01 | 18.14 | 20.66 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.05 | 0.67 | 0.31 | 0.79 | 0.18 | 0.18 |
| Total Income | 16.02 | 21.11 | 18.66 | 19.80 | 18.32 | 20.84 |
| Total Expenditure | 14.77 | 18.40 | 16.23 | 16.88 | 15.78 | 18.54 |
| PBIDT | 1.24 | 2.71 | 2.44 | 2.92 | 2.54 | 2.31 |
| Interest | 0.12 | 0.13 | 0.14 | 0.13 | 0.15 | 0.13 |
| PBDT | 1.12 | 2.58 | 2.30 | 2.79 | 2.39 | 2.18 |
| Depreciation | 0.73 | 0.84 | 0.87 | 0.86 | 0.84 | 0.73 |
| Tax | 0.13 | 0.00 | 0.61 | 0.57 | 0.48 | -0.11 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.04 | 0.51 | -0.17 | -0.29 | 0.10 | 0.45 |
| Reported Profit After Tax | 0.30 | 1.23 | 1.00 | 1.64 | 0.97 | 1.11 |
| Extra-ordinary Items | 0.00 | 0.00 | -0.23 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.30 | 1.23 | 1.23 | 1.64 | 0.97 | 1.11 |
| EPS (Unit Curr.) | 2.48 | 10.21 | 8.31 | 13.69 | 8.06 | 9.25 |
| EPS (Adj) (Unit Curr.) | 2.48 | 10.21 | 8.31 | 13.69 | 8.06 | 9.25 |
| Calculated EPS (Unit Curr.) | 2.48 | 10.21 | 8.31 | 13.69 | 8.06 | 9.25 |
| Calculated EPS (Adj) (Unit Curr.) | 2.48 | 10.21 | 8.31 | 13.69 | 8.06 | 9.25 |
| Calculated EPS (Ann.) (Unit Curr.) | 9.93 | 40.85 | 33.25 | 54.78 | 32.25 | 37.01 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 9.93 | 40.85 | 33.25 | 54.78 | 32.25 | 37.01 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 7.77 | 13.26 | 13.30 | 15.36 | 14.00 | 11.18 |
| PBDTM(%) | 7.02 | 12.62 | 12.53 | 14.68 | 13.18 | 10.55 |
| PATM(%) | 1.88 | 6.02 | 5.45 | 8.63 | 5.35 | 5.37 |
